Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 24345.86. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 18.35%. Today Baxter International Inc., BAX has gained -2.48%, with a current price of 43.65.
Ownership of the company is 10.11% for insider ownership while institutional ownership is 85.50%. The management of the company have seen the company have a payout ratio of 5.50%. Return of assets are at 28.10%, with return on investment at 3.40%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of 0.33. While Total debt/equity is 0.33. With a profit margin of 48.70%, this is combined with a gross margin of 38.60%, and operating margin of -10.70%. Baxter International Inc. ability to meet debt levels, with a current ratio of 2.5, while the quick ratio is 1.9.
For the last year Baxter International Inc., BAX has seen a EPS growth of -79.90%. A performance for the year of 20.28%. The 52-week high is -12.98%, and the 52-week low is 29.27%. The average volume for Baxter International Inc., BAX is 2343289.
With a target price of 53.25, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 5.03 and a forward P/E of 20.91. Perhaps the more useful indicator than P/E, is PEG which has a value of 0.36. Baxter International Inc. also has a P/S and a P/B of 2.41 and 2.81 respectively. For P/cash, Baxter International Inc. has a value of 9.37, while it is 22.32 for P/free cash flow.
At the current price of 43.65, Baxter International Inc. has a dividend yield of 1.16%. We see a return on equity of 56.20%.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 13.80%. In the short-term an EPS growth of 12.21% in the next year is forecasted. This is after a EPS growth of -79.90% for this year and for the last five years a -21.40% growth has been seen.